Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Yin Wilczek
May 29 — The former general counsel of Bio-Rad Laboratories Inc. has sued the company alleging that it fired him for reporting bribery concerns related to China.
In a May 27 complaint filed in the U.S. District Court for the Northern District of California, Sanford Wadler says that after he learned Bio-Rad was involved in extensive Foreign Corrupt Practices Act violations in Russia, Thailand and Vietnam, he investigated—and uncovered—similar activity in China.
Wadler claims that after “repeated stonewalling” from the company's chief executive officer and chief financial officer regarding his concerns, he brought his suspicions to Bio-Rad's audit committee in February 2013. According to the complaint, he was “shocked” when the outside counsel engaged by the company said the following month that it failed to uncover wrongdoing in China during an internal investigation.
Wadler alleges that the company fired him in June 2013, shortly before it was scheduled to present its internal investigation findings to the Securities and Exchange Commission and the Justice Department, because “he refused to be complicit in its wrongdoing.”
A Bio-Rad representative did not immediately respond to a request for comment.
In November, Bio-Rad entered into a non-prosecution agreement to pay $55 million to the SEC and the DOJ to resolve allegations that it failed to prevent its subsidiaries from making improper payments to officials in Russia, Thailand and Vietnam, as well as falsifying records to hide the payments.
At the time the settlement was announced, SEC Enforcement Director Andrew Ceresney said it reflected credit for Bio-Rad's cooperation in the commission's investigation.
To contact the reporter on this story: Yin Wilczek in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Ryan Tuck at email@example.com
The complaint is available at http://www.bloomberglaw.com/public/document/Wadler_v_BioRad_Laboratories_Inc_ et_al_Docket_No_ 315cv02356_ND_Ca.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)